Abstract Body

Background: Dendritic cells (DC), the antigen presenting cells that initiate or shut down adaptive immune responses, exist as two main subsets in peripheral blood namely: myeloid (m)DC, the precursors of tissue DC; and plasmacytoid (p)DC, the main producers of IFN-alpha. Both populations are reduced in HIV-1 infection and their dysfunction has been implicated in HIV-1 immunopathogenesis. The aim of this study was to characterise the impact of HIV-1 on the immunoregulatory functions of peripheral DC, in particular the IFN-alpha blocking immunoglobulin like transcript (ILT)-7 and the T-regulatory (T-reg) inducing receptors, ILT-3 and ILT-4. Methodology: Peripheral blood was collected from three cohorts of patients: healthy controls (n=11), therapy naive patients (n=11), and treated patients (n=11). Cell surface expression of ILT-3, -4, and -7 by pDC and mDC was determined by flow cytometry. For functional studies, pDC and mDC were isolated from healthy donors using magnetically-labelled beads and treated with live HIV-1 IIIB, HIV-1 BAL, or Influenza virus with or without toll like receptor-7 ligand (R848). The ability of DC to stimulate T-reg was determined using co-culture assays followed by intracellular staining for FoxP3. Statistical analysis was performed using the non-parametric Mann-Whitney U test or the Wilcoxon matched pairs test. Significance was defined as p<0.05. Results: Myeloid DC from HIV-1+ patients exhibited normal levels of ILT-3, -4, and -7 regardless of therapy status, whilst pDC from viremic patients expressed significantly higher levels of ILT-3 and lower levels of ILT-7 in comparison to healthy donors and treated patients. Activation of purified pDC with R848 in vitro resulted in a significant reduction in ILT-3 and ILT-4 expression compared to unstimulated pDC. Whilst, treatment of pDC with HIV-1 IIIB failed to reduce ILT-3 levels and resulted in moderate down-modulation of ILT-4, which remained statistically higher than that observed with R848. Co-treatment of pDC with R848 and HIV-1 IIIB, or HIV-1 BAL resulted in reversal of R848-mediated reduction of ILT-3 expression. Functionality of ILT-3 was further confirmed by its cross-linking on pDC that resulted in increased levels of FoxP3+ T-regs. Conclusions: Elevated proportions of circulating pDC displaying higher levels of T-reg inducing molecules with a predisposition to chronically secrete IFN-alpha through down-regulation of ILT-7 characterise untreated HIV-1 infection. HIV-1 may subvert adaptive immunity through its ability to inhibit full maturation of pDC by blocking activation-induced down-regulation of ILT-3 and ILT-4, potentially leading to raised T-reg activity.